The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Thursday. In afternoon trade, the benchmark index is down 0.5% to 8,882.3 points.
Four ASX shares that are falling more than most today are listed below. Here's why they are dropping:
Image source: Getty Images
Beach Energy Ltd (ASX: BPT)
The Beach Energy share price is down over 4% to $1.20. This follows the release of the energy producer's half-year results. Beach Energy reported a 1% decline in sales revenue to $981.7 million and a 32% drop in net profit after tax to $150.2 million. This reflects a combination of production declines and weaker oil and liquids prices. Beach Energy's CEO, Brett Woods, spoke positively about the second half. He said: "Our steady financial footing and safe operational performance through a challenging half positions Beach for an active second half, particularly as Waitsia ramps up and offshore campaigns progress."
Elders Ltd (ASX: ELD)
The Elders share price is down 4% to $7.04. Investors have been selling this agribusiness company's shares after it announced a change of leadership. Elders has named Rene Dedoncker as its new CEO, commencing 1 October 2026. He will be replacing long-serving CEO, Mark Allison. Elders' chair, Glenn Davis, said: "We are delighted to welcome Rene as our next CEO. He brings deep agricultural roots and outstanding leadership experience to Elders. He has proven expertise from his years with Fonterra and Mars, where he drove operational excellence and strategic growth on a global scale. The Board has great confidence in his ability to lead Elders into its next phase of success."
Maas Group Holdings Ltd (ASX: MGH)
The Maas Group share price is down 23% to $4.30. This has been driven by news that the construction materials, equipment and service provider is selling its construction business for $1.7 billion. The company believes the deal will help fund a strategic shift into digital assets. It said: "Just as the Group positioned itself early into renewables-related infrastructure, MGH is now positioning to participate in the next wave of infrastructure investment, combining digital, AI, and electrification opportunities. The Australian data-centre and electrification markets present scalable, high-value opportunities aligned with MGH's execution DNA, integrated capabilities, and program-based delivery."
Neuren Pharmaceuticals Ltd (ASX: NEU)
The Neuren share price is down 10% to $13.19. This follows the release of an update on its NNZ-2591 product candidate. While the US FDA has given Neuren a pathway forward for advancing NNZ-2591 in two rare neurological conditions, some additional work will be required. This could mean it takes longer than expected for approval.
